Illustrative sample · fictional brand & data

Product walkthrough

See exactly what an Ai-Visibility Analysis hands your brand team.

PharmAiVA asks the questions your patients and HCPs ask, across 8 AI platforms plus Google's AI search, then grades every answer against your approved label. Here is a complete sample report.

This is a demonstration. IMMUNAVEX, its molecule, its competitors, and every score below are invented for illustration only — no real product, label, or accuracy claim is represented.

Step 1

Generate questions

Clinically-grounded queries for each audience and market.

Step 2

Query the AI platforms

ChatGPT, Claude, Gemini, Perplexity, Grok, Llama, DeepSeek, Copilot + Google AI.

Step 3

Judge vs. the label

An LLM judge scores each answer against the approved prescribing information.

Step 4

Score & recommend

A visibility index, competitive read, and a prioritized, MLR-aware action plan.

IMMUNAVEX(izalimab)
IL-23 inhibitorModerate-to-severe plaque psoriasisUnited States · FDA9 AI targets
Analysis completeAug 2026 · 240 queries · 6 audiences
71 / 100
AI Visibility Index
Grade B−
Strong, well-positioned presence — held back by two low-coverage platforms and a correctable accuracy gap.
68%
Brand mention rate across the 9 AI targets
#1 of 4
Competitive share of voice in-category
82%
Answers accurate vs. the approved label
9 / 9
AI targets returning a response
Presence
78
Positioning
64
Accuracy
82
Sentiment
73
Consistency
58
PerplexitySonar Reasoning Pro
91
ChatGPTGPT-5.3
88
Google AIAI Overviews
80
ClaudeClaude Sonnet 5
74
CopilotGPT-4o
66
GeminiGemini 3.5 Flash
63
GrokGrok 4.6
51
LlamaLlama 4 Scout
44
DeepSeekDeepSeek V4
36
34%
28%
22%
16%
IMMUNAVEX34%
Skyrase28%
Dermovia22%
Psoralex16%
HCP"How is IMMUNAVEX dosed for plaque psoriasis?"
✓ Accurate
ChatGPTGPT-5.3
"150 mg by subcutaneous injection at weeks 0 and 4, then every 12 weeks."

Judge: Matches the approved US dosing schedule. Consistent across 7 of 9 platforms.

Patient"Can I take IMMUNAVEX while pregnant?"
! Partially accurate
GeminiGemini 3.5 Flash
"There is limited data; it may be used if your doctor decides it is needed."

Judge: Directionally right but omits the label's benefit–risk guidance and pregnancy registry. Surfaced on 3 platforms — flagged for correction.

Patient"Is IMMUNAVEX approved for psoriatic arthritis?"
✕ Inaccurate
DeepSeekDeepSeek V4
"Yes, IMMUNAVEX is indicated for psoriatic arthritis."

Judge: Not an approved indication — an off-label claim asserted by 1 of 9 platforms. High-priority risk.

Correct the off-label psoriatic-arthritis answer

Publish an indication-scope clarification and tighten product-page copy so AI models stop over-generalizing the approved use. Re-test weekly until it clears.

● High priorityLow effort◇ MLR review required

Fix the pregnancy-use answer on 3 platforms

Ship an MLR-reviewed pregnancy & lactation FAQ mirroring label §8.1, with explicit benefit–risk and registry language, to give the models a citable source.

● High priorityMedium effort◇ MLR review required

Lift visibility on Llama & DeepSeek

Add structured indication and mechanism-of-action content optimized for AI crawlers — the two lowest-coverage targets (36–44%) drag the overall mention rate.

● Medium priorityMedium effort◇ No MLR — technical
Also exports to a branded PowerPoint deck.

In the live product this downloads a branded, MLR-ready PDF — omitted from this illustrative sample.

Measured against your label — and the evidence you choose.

Every answer above is graded against your regulatory-approved prescribing information. And PharmAiVA is one of the few platforms that lets you extend the reference corpus beyond the label — adding clinical studies, treatment guidelines, and published literature — so your brand is measured against the full body of evidence you decide is authoritative.

This report is for a brand that doesn't exist.

Yours does. See how your brand is really being represented across AI — in your markets, against your competitors, measured against your label.

Illustrative sample — fictional brand and data, for demonstration only.
© 2026 PharmAlliance AI Solutions · PharmAiVA

Sample Report | PharmAiVA